PEAK6’s Labcorp LH Stock Holding History

PEAK6’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30,000	Closed	-$7.53M	–	3029
2025 Q4	$7.53M	Sell	30,000 -9,200	-23%	-$2.44M	0.01%	771
2025 Q3	$11.3M	Sell	39,200 -11,000	-22%	-$2.95M	0.02%	638
2025 Q2	$13.2M	Buy	+50,200	New	+$12.2M	0.02%	521

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PEAK6's LH Position: Q4 2025 in Review

PEAK6 sold out of Labcorp (LH) in Q4 2025, closing a stake of 2 shares — an estimated $531 sold.

PEAK6 first reported a position in LH in Q2 2025 and held it in 2 quarters. The position peaked at $756 in Q2 2025. 1,024 funds tracked by Wall St. Rank hold LH as of Q4 2025.

PEAK6 reported no remaining Labcorp position as of Q4 2025 after selling out during the quarter.
PEAK6 sold 2 Labcorp shares in Q4 2025, an estimated $531.
PEAK6 first reported a position in Labcorp in Q2 2025 and held it in 2 quarters.
PEAK6's Labcorp position peaked at $756 in Q2 2025.
1,024 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.

Based on PEAK6's 13F filing for Q4 2025, filed 13 Feb 2026.